Funding
This study was performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-DIRECT; 11039020) and the Japan Agency for Medical Research and Development (AMED; 15cm0106085h0005) to Shoichi Hazama, and also by the Japan Society for the Promotion of Science KAKENHI under grant number JP20K09079 to Shin Yoshida.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Tsunenori Yamamoto, Ryouichi Tsunedomi, Masao Nakajima, Nobuaki Suzuki, Shin Yoshida, Shinobu Tomochika, Ming Xu, Yuki Nakagami, Hiroto Matsui, Yukio Tokumitsu, Yoshitaro Shindo, Yusaku Watanabe, Michihisa Iida, Shigeru Takeda, Shoichi Hazama, Tsuyoshi Tanabe, Tatsuya Ioka, Yoshinobu Hoshii, Akifumi Kiyota, Hitoshi Takizawa, Yutaka Kawakami, Tomio Ueno, and Hiroaki Nagano declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yamamoto, T., Tsunedomi, R., Nakajima, M. et al. ASO Visual Abstract: Interleukin-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer. Ann Surg Oncol 30, 5280–5281 (2023). https://doi.org/10.1245/s10434-023-13644-8
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13644-8